PubMed, Pham, Hung, et al
They found that those taking 0.5 mg of semaglutide lost an average of 8.3% of their body weight after 12 months of treatment
The Final Verdict While the idea of weight loss patches may seem appealing, they fall short of delivering the transformative results of GLP-1 injections
It also acts on appetite centers in the hypothalamus, reducing hunger signals and food intake
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
Week 4: Seeing the Bigger Picture Noticeable Changes Patients often report looser clothes, improved confidence, and better control over eating